Cargando…

Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis

OBJECTIVE: Systematic Review was used to evaluate the efficacy and safety of Dalfampridine (DAP) in the treatment of Mobility Disability (MS) in patients with Multiple Sclerosis. METHODS: Clinical randomized controlled studies about DAP and placebo in the treatment of Mobility Disability in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jianzhen, Wu, Xiaohui, Chen, Yanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742383/
https://www.ncbi.nlm.nih.gov/pubmed/31513613
http://dx.doi.org/10.1371/journal.pone.0222288